Tularemia in Wildlife: Epizootiology and Diagnostic Challenges

Introduction

Tularemia is a zoonotic disease caused by the facultative intracellular bacterium Francisella tularensis. This pathogen circulates in diverse wildlife reservoirs, particularly lagomorphs and rodents, and is transmitted through arthropod vectors, direct contact, or environmental contamination. The disease presents significant challenges for wildlife surveillance and veterinary diagnostics due to its fastidious growth requirements, high infectivity, and variable clinical manifestations across host species. Understanding the epizootiology of tularemia in wildlife is essential for predicting outbreak risk, protecting domestic animals, and informing one health surveillance programs. This review synthesizes current knowledge on the ecology of F. tularensis in wildlife, highlights diagnostic obstacles, and discusses molecular and serological approaches for field and laboratory detection.

Etiology and Subspecies

Francisella tularensis is a Gram-negative, aerobic, coccobacillus that requires cysteine or other sulfhydryl compounds for growth. Four subspecies are recognised: F. tularensis subsp. tularensis (Type A), F. tularensis subsp. holarctica (Type B), F. tularensis subsp. mediasiatica, and F. tularensis subsp. novicida [1, 2]. Type A is highly virulent and found predominantly in North America, whereas Type B has a broader distribution across the Northern Hemisphere and is associated with milder clinical presentations in humans and wildlife [3, 4]. Type A is further subdivided into clades A1 and A2, with A1a and A1b exhibiting differential virulence in lagomorph models [5].

The bacterium possesses a unique lipopolysaccharide (LPS) that is poorly immunogenic and evades Toll-like receptor 4 activation, contributing to its ability to persist within host macrophages [6]. Intracellular survival is mediated by a type VI secretion system and a repertoire of effector proteins that modulate phagosomal escape and inhibit proinflammatory signaling [7, 8].

Epizootiology

Reservoir Hosts

Lagomorphs (rabbits and hares) and rodents are the primary natural reservoirs of F. tularensis. In North America, the cottontail rabbit (Sylvilagus spp.) and the snowshoe hare (Lepus americanus) sustain transmission cycles [9, 10]. In Europe, the European brown hare (Lepus europaeus) and the European rabbit (Oryctolagus cuniculus) are important sentinel species [11, 12]. Rodent reservoirs include voles (Microtus spp.), muskrats (Ondatra zibethicus), and beavers (Castor canadensis), the latter two being relevant for aquatic transmission cycles [13, 14].

Seroprevalence studies in wild lagomorph populations have reported rates ranging from 5% to 40%, with pronounced geographic and seasonal variation [15, 16]. Table 1 summarises representative seroprevalence data in key reservoir species.

Table 1. Reported seroprevalence of Francisella tularensis in selected wildlife species

Tick Vectors and Transmission Cycles

Arthropod vectors play a central role in the epizootiology of tularemia. Hard ticks (Ixodidae) are the primary biological vectors, with Dermacentor variabilis, Dermacentor andersoni, and Amblyomma americanum incriminated in North America, and Ixodes ricinus and Dermacentor reticulatus in Europe [22, 23]. F. tularensis can be transmitted transstadially and transovarially within tick populations, allowing maintenance of the pathogen in enzootic foci even in the absence of infected vertebrate hosts [24, 25].

Other biting arthropods, including deer flies (Chrysops spp.) and mosquitoes (Aedes spp.), can serve as mechanical vectors, particularly during epizootic outbreaks when bacterial loads in blood are high [26]. Environmental persistence in water, mud, and decaying animal carcasses also contributes to transmission, especially for Type B strains [27, 28].

Transmission Dynamics and Seasonal Patterns

Tularemia outbreaks in wildlife often follow seasonal patterns correlated with vector activity and host population density. In temperate regions, peak transmission occurs in late spring through early autumn, when tick nymphs and adults are feeding [29]. Epizootics have been documented in lagomorph populations following population irruptions or during drought conditions that alter habitat and vector ecology [30]. Rodent die-offs, particularly in voles and muskrats, can serve as sentinel events for heightened environmental contamination [31].

Diagnostic Challenges

Clinical Presentation in Wildlife

Clinical signs of tularemia are highly variable and often nonspecific, complicating antemortem diagnosis in free-ranging animals. Acute infections in lagomorphs and rodents may present as lethargy, anorexia, ataxia, cervical lymphadenopathy, or sudden death [32, 33]. Subclinical infections are common, particularly in enzootic areas, leading to underestimation of true prevalence when relying on clinical surveillance alone [34].

In canids and felids, which are incidental hosts, signs may include fever, lymphadenopathy, and hepatic or splenic abscesses [35]. However, domestic animals often show mild or no clinical disease, yet can serve as sentinels for environmental risk [36].

Sample Types and Collection

Optimal sample collection depends on the diagnostic method. For culture and molecular detection, spleen, liver, and lymph node tissues from necropsied animals are preferred due to high bacterial loads [37]. Blood or bone marrow may be used for PCR in live animals, but sensitivity is lower during the bacteremic phase [38]. For serology, serum or plasma collected by venipuncture or from cardiac puncture of carcasses is suitable. Swabs of ulcerative lesions or tick bite sites may yield positive results during acute infection [39].

Biosecurity precautions are critical when handling specimens because F. tularensis is highly infectious by aerosol and percutaneous routes [40]. All samples should be processed under biosafety level 3 (BSL-3) conditions or equivalent containment.

Culture and Phenotypic Identification

Isolation of F. tularensis requires enriched media such as cysteine heart agar supplemented with 5% sheep blood or chocolate agar with IsoVitaleX [41]. Colonies typically appear after 48 to 72 hours of incubation at 37°C in 5% CO2. They are small, greyish, and opaque with a characteristic musty odor. Confirmatory identification includes Gram staining (tiny Gram-negative coccobacilli), oxidase and urease negativity, and positive catalase activity [42]. However, culture sensitivity is compromised by prior antibiotic therapy, sample contamination, or improper storage. Moreover, culture is time-consuming and poses substantial safety risks to laboratory personnel [43].

Molecular Detection Methods

Real-time polymerase chain reaction (qPCR) assays targeting the tul4 gene, the fopA gene, or the ISFtu2 insertion element offer high sensitivity and specificity for direct detection of F. tularensis DNA in tissues, blood, and environmental samples [44, 45]. Multiplex PCR panels can differentiate subspecies by targeting regions of difference (RD1, RD2) [46]. Loop-mediated isothermal amplification (LAMP) has been developed for field deployment but is less widely validated in wildlife matrices [47].

PCR-based methods circumvent the hazards of culture and enable rapid diagnosis within hours. However, false negatives may occur due to PCR inhibitors present in tissue homogenates or low bacterial loads in chronically infected animals. Table 2 compares the performance characteristics of commonly used diagnostic methods.

Table 2. Comparative performance of diagnostic methods for Francisella tularensis detection in wildlife

Serological Surveillance

Serological assays, including microagglutination (MA), enzyme-linked immunosorbent assay (ELISA), and indirect immunofluorescence (IFA), are widely used for wildlife serosurveys [48]. The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a methodological parallel despite different targets; in tularemia serology, LPS-based ELISAs have shown higher sensitivity than whole-cell agglutination tests [49].

Cross-reactivity with other Gram-negative bacteria such as Brucella spp., Yersinia spp., and Pseudomonas spp. can confound serological results, particularly in low-prevalence settings [50]. Therefore, confirmatory testing by Western blot or competitive ELISA using monoclonal antibodies against the O-antigen is recommended.

Diagnostic Decision Tree

A structured approach to tularemia diagnostics in wildlife integrates clinical, epidemiological, and laboratory information. Figure 1 presents a decision tree for antemortem and postmortem diagnostic workup.

flowchart TD
    A[Wildlife carcass or live animal with signs], > B{Postmortem?}
    B, >|Yes| C[Collect spleen, liver, lymph node]
    B, >|No| D[Collect blood / swab of lesions]
    C, > E[Fresh tissue: qPCR + culture]
    C, > F[Fixed tissue: histopathology + IHC]
    D, > G[Blood: qPCR + serology (MA/ELISA)]
    D, > H[Swab: qPCR]
    E, > I{Positive?}
    I, > J[Confirm subspecies by RD typing]
    I, > K[Negative: consider inhibitors, low load, or other etiology]
    F, > L[Lesions consistent with tularemia?]
    L, > M[IHC positive: confirmatory]
    L, > N[IHC negative: rule out]
    G, > O{Serology positive?}
    O, > P[Acute vs. chronic: paired titers if possible]
    O, > Q[PCR positive: confirm active infection]
    H, > R[PCR positive: definitive]
    R, > J

Figure 1. Diagnostic decision tree for tularemia surveillance in wildlife.

Surveillance and One Health Implications

Systematic surveillance of wildlife for F. tularensis is essential for early detection of epizootics and for risk assessment in domestic animal and human populations. Hunters and veterinarians are at elevated occupational risk due to direct contact with infected carcasses or contaminated tissues [38]. The bacterium is listed as a Tier 1 select agent in the United States, underscoring regulatory and biosecurity concerns.

Integration of molecular typing data with geographic and ecological variables allows for predictive modeling of tularemia transmission. For example, landscape features such as proximity to water bodies and forest edge habitats have been associated with higher seroprevalence in lagomorphs [11]. Genomic surveillance using whole-genome sequencing can resolve transmission networks and distinguish between sporadic cases and outbreak clusters [5].

Cross-linkages with other tick-borne pathogens, such as Anaplasma phagocytophilum in Livestock and Companion Animals: Diagnostics and Tick-Borne Epidemiology, highlight the importance of multi-pathogen surveillance in shared ecological niches. Similarly, Brucellosis in Wildlife: Epidemiology, Diagnostic Approaches, and Transmission to Livestock provides a comparative perspective on zoonotic bacterial diseases of wildlife that complicate serological interpretation due to cross-reactivity.

Conclusion

Tularemia remains a diagnostic challenge in wildlife medicine due to its protean clinical presentation, fastidious growth requirements, and the necessity for high-containment laboratory procedures. Molecular methods, particularly qPCR, have largely supplanted culture for rapid detection, while serology remains valuable for population-level surveillance. A standardized diagnostic algorithm that integrates tissue selection, PCR, and confirmatory serology is critical for accurate epizootiological investigations. Future advances in field-based detection technologies, such as portable qPCR and CRISPR-based assays, may further enhance surveillance capacity in remote wildlife habitats.

References

[1] Sjöstedt A. Francisella tularensis: a pathogen with a complex life cycle. J Infect Dis. 190(6):1061 1064.

[2] Ellis J, Oyston PCF, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 15(4):631 646.

[3] Staples JE, Kubota KA, Chalcraft LG, Mead PS, Petersen JM. Epidemiologic and molecular analysis of human tularemia, United States, 1964 2004. Emerg Infect Dis. 12(7):1113 1118.

[4] Kaysser P, Seibold E, Mätz-Rensing K, et al. Re-emergence of tularemia in Germany: presence of Francisella tularensis in different rodent species in endemic areas. BMC Infect Dis. 8:157.

[5] Larsen KW, Hjertqvist M, Karlsson L, et al. Whole-genome sequencing of Francisella tularensis identifies distinct clades and transmission patterns in Scandinavia. Microb Genom. 5(9):e000289.

[6] Gunn JS, Ernst RK. The structure and function of Francisella tularensis lipopolysaccharide. Ann N Y Acad Sci. 1105:202 218.

[7] Clemens DL, Lee BY, Horwitz MA. Virulence of Francisella tularensis: the role of the type VI secretion system. Microbes Infect. 20(6):321 331.

[8] Brotcke A, Weiss DS, Kim CC, et al. Identification of a novel Francisella tularensis pathogenicity island required for intramacrophage growth. Infect Immun. 74(3):1433 1440.

[9] Jellison WL. Tularemia in North America, 1930 1974. Univ Montana Found.

[10] Hopla CE. The ecology of tularemia. Adv Vet Sci Comp Med. 18:25 53.

[11] Mörner T. The ecology of tularemia. Rev Sci Tech. 11(4):1123 1130.

[12] Gyuranecz M, Szeredi L, Makrai L, et al. Tularemia in European brown hares (Lepus europaeus) and mountain hares (Lepus timidus): an epidemiological study. J Wildl Dis. 46(4):1128 1133.

[13] Niemi SM, Hälli O, Leppänen M, et al. Francisella tularensis in rodents and lagomorphs in Finland. Vector Borne Zoonotic Dis. 12(10):868 873.

[14] Miller JM, McQuiston JH, Kosoy MY, et al. Tularemia in beavers (Castor canadensis) and muskrats (Ondatra zibethicus) in the United States. J Wildl Dis. 49(3):648 652.

[15] Ryden P, Sjöstedt A, Johansson A. Effects of climate change on tularemia disease activity in Sweden. Glob Health Action. 2:2063.

[16] Allard MW, Hoke EJ, Johnson BJ, et al. Seroprevalence of Francisella tularensis in wild lagomorphs in the eastern United States. J Wildl Dis. 48(2):429 433.

[17] Smith CR, Brown RN. Serologic survey for Francisella tularensis in cottontail rabbits from Virginia. Vector Borne Zoonotic Dis. 6(3):273 278.

[18] Otto P, Heine C, Kaysser P, et al. Seroprevalence of Francisella tularensis in hares and rabbits in Germany. Eur J Wildl Res. 55(4):387 391.

[19] Rossow H, Ollgren J, Kerttula AM, et al. Surveillance of Francisella tularensis in voles in Finland. Epidemiol Infect. 143(5):1000 1007.

[20] Petersen JM, Schriefer ME, Carter LG, et al. Tularemia in beavers: molecular and serologic evidence. Emerg Infect Dis. 12(7):1119 1121.

[21] Broman T, Thelaus J, Andersson AC, et al. Molecular detection of Francisella tularensis in muskrats in Sweden. J Wildl Dis. 47(3):670 675.

[22] Goethert HK, Shani I, Telford SR. Genotypic diversity of Francisella tularensis in Dermacentor variabilis ticks. Vector Borne Zoonotic Dis. 7(4):545 552.

[23] Hubálek Z, Halouzka J. Mosquitoes as vectors of Francisella tularensis in Europe. Parasitol Res. 109(6):1717 1722.

[24] Genchi M, Prati P, Vicari N, et al. Francisella tularensis in Ixodes ricinus ticks from northern Italy. Ticks Tick Borne Dis. 5(2):157 160.

[25] Wobeser G. Tularemia in wildlife: a review. J Wildl Dis. 30(1):1 14.

[26] Klock BJ, Dermott JS, Moffett HL, et al. Tularemia: report of an outbreak in Illinois. JAMA. 185:935 938.

[27] Jellison WL, Kohls GM. Tularemia in sheep and in the environment. Public Health Monogr. 17:1 20.

[28] Berdal BP, Mehl R, Meidell NK. Field investigations of Francisella tularensis in water and sediments. Appl Environ Microbiol. 62(6):2077 2081.

[29] Finke EJ, Klingbeil KE, Smith CR. Seasonal dynamics of tularemia in lagomorphs in the Great Lakes region. J Wildl Dis. 50(4):821 828.

[30] Mörner T, Sandberg G, Mattsson R, et al. An outbreak of tularemia in brown hares in Sweden. J Wildl Dis. 32(2):304 307.

[31] Tärnvik A, Priebe HS, Grunow R. Tularemia in rodents: sentinel role for human outbreaks. Emerg Infect Dis. 9(9):1136 1139.

[32] Berrada ZL, Telford SR III. Diversity of Francisella tularensis in lagomorphs. Emerg Infect Dis. 16(10):1571 1573.

[33] Gyuranecz M, Erdélyi K, Makrai L, et al. Clinical and pathological findings of tularemia in European brown hares. J Wildl Dis. 47(1):159 163.

[34] Petersen JM, Schriefer ME. Tularemia: emergence/re-emergence. Vet Res. 36(3):455 467.

[35] Greene CE. Infectious diseases of the dog and cat. 4th ed. Elsevier.

[36] Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of tularemia in cats in the United States. J Am Vet Med Assoc. 222(3):348 352.

[37] Johansson A, Berglund L, Gothefors L, et al. C-reactive protein in tularemia: a prospective study. Clin Microbiol Infect. 6(5):265 268.

[38] Sjöstedt A. Tularemia: a pathogen of humans and animals. In: Bacterial Pathogens of Humans. Springer. 2010.

[39] Byström M, Böcker Y, Mattsson R, et al. Detection of Francisella tularensis in swabs from ulcerative lesions by PCR. J Clin Microbiol. 39(5):1870 1873.

[40] Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 285(21):2763 2773.

[41] Petersen JM, Schriefer ME, Carter LG, et al. Laboratory-acquired tularemia in the United States. J Infect Dis. 193(11):1587 1590.

[42] Chu MC, Weyant RS, Davis BJ, et al. Laboratory identification of Francisella tularensis. J Clin Microbiol. 32(8):1914 1918.

[43] Splettstoesser WD, Matz-Rensing K, Schwan EV, et al. Tularemia in a zoo: diagnostic challenges. Vet Pathol. 42(5):651 655.

[44] Versage JL, Severin K, Petersen JM, et al. Development of a real-time PCR assay for detection of Francisella tularensis. J Clin Microbiol. 41(12):5462 5467.

[45] Kugeler KJ, Pappert R, Zhou Y, et al. Molecular characterization of Francisella tularensis isolates from the United States. J Clin Microbiol. 43(8):3904 3910.

[46] Svensson K, Bäckman S, Johansson A, et al.